MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 70 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $69 | +4.5% | 12,257 | -11.6% | 0.00% | 0.0% |
| Q3 2023 | $66 | -36.5% | 13,866 | +3.4% | 0.00% | 0.0% |
| Q1 2023 | $104 | +28.4% | 13,411 | +26.1% | 0.00% | 0.0% |
| Q4 2022 | $81 | -99.9% | 10,632 | -6.1% | 0.00% | 0.0% |
| Q2 2022 | $109,000 | -19.3% | 11,319 | +71.0% | 0.00% | 0.0% |
| Q4 2021 | $135,000 | -16.1% | 6,621 | -8.5% | 0.00% | 0.0% |
| Q3 2021 | $161,000 | – | 7,238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,692,298 | $43,461,484 | 2.90% |
| Aisling Capital Management LP | 1,472,331 | $8,318,670 | 2.48% |
| Alphabet Inc. | 1,464,015 | $8,271,684 | 0.38% |
| Avoro Capital Advisors LLC | 4,535,000 | $25,622,750 | 0.35% |
| Baker Brothers Advisors | 4,916,095 | $27,775,937 | 0.32% |
| Casdin Capital, LLC | 510,882 | $2,886,483 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 48,511 | $274,087 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $157,319 | 0.03% |
| Caption Management, LLC | 224,300 | $1,267,295 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 44,247 | $249,996 | 0.01% |